These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 17294242)

  • 1. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
    Jinawath A; Akiyama Y; Sripa B; Yuasa Y
    J Cancer Res Clin Oncol; 2007 Apr; 133(4):271-8. PubMed ID: 17294242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway.
    Lu JT; Zhao WD; He W; Wei W
    Acta Pharmacol Sin; 2012 May; 33(5):691-700. PubMed ID: 22543708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance and therapeutic potential of hedgehog signaling in intrahepatic cholangiocellular carcinoma.
    Tang L; Tan YX; Jiang BG; Pan YF; Li SX; Yang GZ; Wang M; Wang Q; Zhang J; Zhou WP; Dong LW; Wang HY
    Clin Cancer Res; 2013 Apr; 19(8):2014-24. PubMed ID: 23493353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
    Yip-Schneider MT; Schmidt CM
    Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.
    Seubwai W; Wongkham C; Puapairoj A; Okada S; Wongkham S
    Cancer; 2010 Dec; 116(23):5535-43. PubMed ID: 20681031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells.
    Fingas CD; Bronk SF; Werneburg NW; Mott JL; Guicciardi ME; Cazanave SC; Mertens JC; Sirica AE; Gores GJ
    Hepatology; 2011 Dec; 54(6):2076-88. PubMed ID: 22038837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells.
    Park JM; Xian XS; Choi MG; Park H; Cho YK; Lee IS; Kim SW; Chung IS
    J Cell Biochem; 2011 Apr; 112(4):1192-205. PubMed ID: 21312237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression.
    Georgakis GV; Li Y; Rassidakis GZ; Medeiros LJ; Younes A
    Exp Hematol; 2006 Dec; 34(12):1670-9. PubMed ID: 17157164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
    Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X
    Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
    Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
    Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog pathway as a potential treatment target in human cholangiocarcinoma.
    Riedlinger D; Bahra M; Boas-Knoop S; Lippert S; Bradtmöller M; Guse K; Seehofer D; Bova R; Sauer IM; Neuhaus P; Koch A; Kamphues C
    J Hepatobiliary Pancreat Sci; 2014 Aug; 21(8):607-15. PubMed ID: 24733827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.
    Matsumoto K; Okano J; Nagahara T; Murawaki Y
    Int J Oncol; 2006 Dec; 29(6):1501-8. PubMed ID: 17088989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins.
    Bai L; Mao R; Wang J; Ding L; Jiang S; Gao C; Kang H; Chen X; Sun X; Xu J
    Med Oncol; 2015 Mar; 32(3):57. PubMed ID: 25647783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression.
    Gao QZ; Lu JJ; Liu ZD; Zhang H; Wang SM; Xu H
    Asian J Androl; 2008 Jul; 10(4):635-41. PubMed ID: 18097517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment.
    Dokduang H; Juntana S; Techasen A; Namwat N; Yongvanit P; Khuntikeo N; Riggins GJ; Loilome W
    Tumour Biol; 2013 Dec; 34(6):3519-28. PubMed ID: 23812726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
    Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
    Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
    Cusimano A; Foderà D; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G; Cervello M
    Cancer Biol Ther; 2007 Sep; 6(9):1461-8. PubMed ID: 18424914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.
    Fingas CD; Mertens JC; Razumilava N; Sydor S; Bronk SF; Christensen JD; Ilyas SI; Canbay A; Treckmann JW; Paul A; Sirica AE; Gores GJ
    Hepatology; 2013 Oct; 58(4):1362-74. PubMed ID: 23703673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.